Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 100Thoracic 17Genitourinary 15Gynecologic 12Dermatologic 9CNS 8Sarcoma 7Head & Neck 7Breast 5Endocrine 4Plasma cell 3Lymphoid 3NET 2Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Advanced Solid Tumors 35Advanced Solid Tumor 22Solid Tumors 17Mesothelioma 16Solid Tumor 12Mesothelioma, Malignant 11Hematopoietic and Lymphatic System Neoplasm 10Ovarian Neoplasms 7Solid Tumor, Adult 5Pancreatic Neoplasms 5Malignant Solid Neoplasm 5Solid Tumours 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Kidney Neoplasms 3Advanced or Metastatic Solid Tumors 3Advanced Malignant Solid Tumors 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thymus Neoplasms 2Solid Tumor Malignancies 2Solid Tumor Cancer 2Retinoblastoma 2Rectal Neoplasms 2Neoplasms 2Metastatic Solid Tumors 2

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Other solid neoplasm × 30 days × Clear all
NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
320 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡